CFO transition
TransAct Technologies Incorporated CFO transition: Troy W. Ingianni to succeed Steven A. DeMartino
TransAct Technologies Incorporated reported in a Form 8-K filed June 29, 2026 that Troy W. Ingianni will succeed Steven A. DeMartino as Chief Financial Officer, Secretary and Treasurer, effective July 1, 2026.
In the filing's words
on June 26, 2026, the Board appointed Troy W. Ingianni to serve as the Company’s Chief Financial Officer, Secretary and Treasurer, effective July 1, 2026 (the “Start Date”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | TransAct Technologies Incorporated (TACT) |
|---|---|
| Event | Transition |
| Incoming | Troy W. Ingianni |
| Outgoing | Steven A. DeMartino |
| Title in the filing | Chief Financial Officer, Secretary and Treasurer |
| Effective | July 1, 2026 |
| 8-K filed | June 29, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Vice President, Global Controller and Chief Accounting Officer, Barnes Group Inc. |
| SEC CIK | 0001017303 |
TransAct Technologies Incorporated reported this change in a Form 8-K, Item 5.02, filed June 29, 2026. The filing's own words are quoted above.
Other records naming Steven A. DeMartino
1The outgoing officer on this record, matched by name. Career line.
2026-03-12 · 10-K signature
Steven A. DeMartino signed TransAct Technologies Incorporated's annual report as President, Chief Financial Officer, Treasurer and Secretary (Principal Financial Officer)
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Troy W. Ingianni? Send a correction with the primary source.